BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 30113661)

  • 1. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Loman BR; Hernández-Saavedra D; An R; Rector RS
    Nutr Rev; 2018 Nov; 76(11):822-839. PubMed ID: 30113661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis.
    Khan MY; Mihali AB; Rawala MS; Aslam A; Siddiqui WJ
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):703-715. PubMed ID: 31009401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis.
    Amini-Salehi E; Hassanipour S; Keivanlou MH; Shahdkar M; Orang Goorabzarmakhi M; Vakilpour A; Joukar F; Hashemi M; Sattari N; Javid M; Mansour-Ghanaei F
    Nutr Rev; 2024 May; 82(6):815-830. PubMed ID: 37550264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Wang LL; Zhang PH; Yan HH
    Front Nutr; 2023; 10():1014010. PubMed ID: 36866059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
    Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM
    World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Yang R; Shang J; Zhou Y; Liu W; Tian Y; Shang H
    Expert Rev Gastroenterol Hepatol; 2021 Dec; 15(12):1401-1409. PubMed ID: 34877910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial.
    Behrouz V; Aryaeian N; Zahedi MJ; Jazayeri S
    J Food Sci; 2020 Oct; 85(10):3611-3617. PubMed ID: 32885440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
    Hadi A; Mohammadi H; Miraghajani M; Ghaedi E
    Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449
    [No Abstract]   [Full Text] [Related]  

  • 9. Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials.
    Zheng HJ; Guo J; Wang Q; Wang L; Wang Y; Zhang F; Huang WJ; Zhang W; Liu WJ; Wang Y
    Crit Rev Food Sci Nutr; 2021; 61(4):577-598. PubMed ID: 32329633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
    Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of probiotics, prebiotics, and synbiotics in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Rong L; Ch'ng D; Jia P; Tsoi KKF; Wong SH; Sung JJY
    J Gastroenterol Hepatol; 2023 Oct; 38(10):1682-1694. PubMed ID: 37409560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
    Wang W; Shi LP; Shi L; Xu L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):101-106. PubMed ID: 29397594
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
    Kanchanasurakit S; Kositamongkol C; Lanoi K; Nunta M; Saetuan T; Chaiyakunapruk N; Saokaew S; Phisalprapa P
    Front Nutr; 2022; 9():880014. PubMed ID: 35669067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
    Liu L; Li P; Liu Y; Zhang Y
    Dig Dis Sci; 2019 Dec; 64(12):3402-3412. PubMed ID: 31203554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis.
    Jin H; Xu X; Pang B; Yang R; Sun H; Jiang C; Shao D; Shi J
    Benef Microbes; 2021 Nov; 12(6):517-529. PubMed ID: 34511051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study.
    Naghipour A; Amini-Salehi E; Orang Gorabzarmakhi M; Shahdkar M; Fouladi B; Alipourfard I; Sanat ZM
    Syst Rev; 2023 Aug; 12(1):144. PubMed ID: 37605283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.
    Sharpton SR; Maraj B; Harding-Theobald E; Vittinghoff E; Terrault NA
    Am J Clin Nutr; 2019 Jul; 110(1):139-149. PubMed ID: 31124558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses.
    Mahapatro A; Bawna F; Kumar V; Daryagasht AA; Gupta S; Raghuma N; Moghdam SS; Kolla A; Mahapatra SS; Sattari N; Amini-Salehi E; Nayak SS
    Clin Nutr ESPEN; 2023 Oct; 57():475-486. PubMed ID: 37739694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical effect of probiotics on patients with non-alcoholic fatty liver disease: a meta-analysis.
    Wang Y; Wang Y; Sun J
    Bioengineered; 2022; 13(7-12):14960-14973. PubMed ID: 37105767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.